BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23913682)

  • 1. Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.
    Xia H; Wang C; Chen W; Zhang H; Chaudhury L; Zhou Z; Liu R; Chen C
    J Biol Chem; 2013 Sep; 288(37):26731-40. PubMed ID: 23913682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
    Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
    Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression.
    Stamatakis K; Jimenez-Martinez M; Jimenez-Segovia A; Chico-Calero I; Conde E; Galán-Martínez J; Ruiz J; Pascual A; Barrocal B; López-Pérez R; García-Bermejo ML; Fresno M
    Oncotarget; 2015 Nov; 6(37):39941-59. PubMed ID: 26498686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.
    Liu R; Zhou Z; Zhao D; Chen C
    Mol Endocrinol; 2011 Jul; 25(7):1137-44. PubMed ID: 21566082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X; Zhao D; Zhou Z; Liu R; Chen C
    Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.
    Zhou X; Li D; Resnick MB; Wands J; Cao W
    Mol Pharmacol; 2013 May; 83(5):978-90. PubMed ID: 23439561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
    Liu R; Zheng HQ; Zhou Z; Dong JT; Chen C
    J Biol Chem; 2009 Jun; 284(25):16791-16798. PubMed ID: 19411256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.
    Guo P; Dong XY; Zhao KW; Sun X; Li Q; Dong JT
    Int J Cancer; 2010 Jan; 126(1):81-9. PubMed ID: 19569049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3β-mediated signal transduction in colon cancer cells.
    Yu S; Hou Q; Sun H; Liu J; Li J
    Mol Med Rep; 2015 Nov; 12(5):7169-75. PubMed ID: 26352871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
    Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
    J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.
    Dong Z; Yang L; Lai D
    Cell Prolif; 2013 Aug; 46(4):425-35. PubMed ID: 23869764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
    Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
    Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
    Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
    Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
    Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
    Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155.
    Kim S; Lee ES; Lee EJ; Jung JY; Lee SB; Lee HJ; Kim J; Kim HJ; Lee JW; Son BH; Gong G; Ahn SH; Chang S
    J Exp Clin Cancer Res; 2021 Jan; 40(1):43. PubMed ID: 33494773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.
    Takagi K; Miki Y; Onodera Y; Nakamura Y; Ishida T; Watanabe M; Inoue S; Sasano H; Suzuki T
    Endocr Relat Cancer; 2012 Dec; 19(6):741-50. PubMed ID: 22936544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    Ma D; Pan Z; Chang Q; Zhang JJ; Liu X; Hua N; Li GH
    BMC Cancer; 2021 Apr; 21(1):377. PubMed ID: 33827480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.
    Jia L; Zhou Z; Liang H; Wu J; Shi P; Li F; Wang Z; Wang C; Chen W; Zhang H; Wang Y; Liu R; Feng J; Chen C
    Oncogene; 2016 Apr; 35(16):2040-51. PubMed ID: 26189798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.